Stemline Targeting cancer at its root
developing novel drugs that attack Cancer Stem Cells


The Company
Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells.
Pipeline
Cancer Stem Cells
Platform
Stemline Therapeutics has developed a Discovery Platform called StemScreen® to identify novel compounds that target and kill CSCs.


News
&
Events
6/10/2013
Stemline's SL-401 Receives Orphan Drug Designation for the Treatment BPDCN
5/31/2013
Stemline Therapeutics to Present at Jefferies 2013 Global Healthcare Conference
5/30/2013
Stemline Announces Presentations at the 2013 ASCO Annual Meeting
Copyright 2013 - Stemline Therapeutics, Inc. All rights reserved
Stemline